Jennifer Clements, PharmD, BCPS, CDE, BCACP

Jennifer N. Clements, PharmD, BPCS, CDE, BCACP, reviews some details of the reports of ketocacidosis with the use of SGLT2 inhibitors.

One study demonstrating increased mortality among patients with type 1 diabetes implicates the importance of glycemic control.

Reflections on the drug may raise questions about when to use pramlintide in diabetes.

Jennifer N. Clements, PharmD, BCPS, CDE, BCACP, discusses the pros and cons of liraglutide as a new therapy for weight management.

A new ADA and EASD position statement along with the ADA’s revised Standards of Medical Care in Diabetes have surprising updates.

Evidence shows that the maximum dose of Qsymia is effective for obese patients with type 2 diabetes, but clinicians should still consider all factors.